Feldman Andrew D. sold $7.9M of CBRS

Feldman Andrew D. (CEO, President) sold 37,441 shares of Cerebras Systems Inc. (CBRS) at an average of $210.46 ($199.18–$216.62, $7.88M total) across 16 trades on 2026-09-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Sep 9, 2026, 12:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
medium confidence
Mentioned
$CBRS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishLow
01

Why it matters

The reduction in insider ownership may be interpreted by some traders as a lack of confidence, prompting modest sell orders. However, the planned nature of the trade reduces the likelihood of a sudden price shock.

02

Market read

The filing is a primary source of new information for CBRS shareholders and may generate modest short‑term trading activity.

03

What to watch

Potential upcoming product announcements or financing rounds could offset any short‑term pressure from the sale.

Relevance 5/10Novelty 5/10Timing: post‑market filing on Sep 8, 2026

Background

Form 4 filings provide the first public disclosure of insider transactions. This filing reports a CEO‑initiated sale under a pre‑arranged 10b5‑1 plan.

Company-level read

Ticker impact

$CBRSBearishMedium confidence
Context

CEO Andrew Feldman sold 37,441 shares for $7.9 M via a 10b5‑1 plan, reducing his stake to 16,853 shares.

Expected impact

Likely modest downward pressure in the near term as the market digests the CEO's reduction of holdings.

Evidence & confidence

A $7.9 M sale by the CEO is material for a micro‑cap, but the amount is not large enough to trigger a sharp move; the 10b5‑1 plan indicates pre‑planned execution rather than a reaction to news.

Market effects

Minimal impact on the AI‑hardware sector; insider sales are common and do not alter sector fundamentals.

Limited to U.S. investors tracking micro‑cap AI hardware stocks.

Low; the filing is unlikely to affect broader market sentiment.

Counterpoint

The sale could be a routine liquidity event and not indicative of negative outlook; price may remain stable.

Key entities

  • Cerebras Systems Inc.

    AI‑hardware manufacturer listed on NASDAQ under ticker CBRS.

  • Andrew D. Feldman

    CEO and President of Cerebras Systems, reporting the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.